Passage Bio Future Growth
How is Passage Bio forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?
Future Growth Score
0/6Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
9.5%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 5 | -127 | -123 | -130 | 6 |
| 12/31/2024 | 0 | -136 | -99 | -127 | 7 |
| 12/31/2023 | N/A | -124 | -92 | -120 | 8 |
| 9/30/2022 | N/A | -160 | -137 | -125 | N/A |
| 6/30/2022 | N/A | -180 | -165 | -143 | N/A |
| 3/31/2022 | N/A | -189 | -167 | -141 | N/A |
| 12/31/2021 | N/A | -185 | -153 | -127 | N/A |
| 9/30/2021 | N/A | -173 | -145 | -126 | N/A |
| 6/30/2021 | N/A | -155 | -110 | -102 | N/A |
| 3/31/2021 | N/A | -134 | -92 | -89 | N/A |
| 12/31/2020 | N/A | -112 | -82 | -81 | N/A |
| 9/30/2020 | N/A | -86 | -69 | -69 | N/A |
| 6/30/2020 | N/A | -69 | -63 | -62 | N/A |
| 3/31/2020 | N/A | -56 | -62 | -62 | N/A |
| 12/31/2019 | N/A | -46 | -42 | -40 | N/A |
| 9/30/2019 | N/A | -38 | -45 | -41 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PASG is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: PASG is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: PASG is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: PASG is forecast to have no revenue next year.
High Growth Revenue: PASG is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PASG is forecast to be unprofitable in 3 years.